Table 1.

Clinical characteristics of patients with B-cell NHL


Patient no.

Hem ID

Sex

Age, y

Histology

Biopsy date

Treatment

Tissue
1   MF634   M   40   DLBCL   6/28/2004   New   Node  
2   MF644   M   69   DLBCL   7/9/2004   New   Spleen  
3   MF650   F   60   DLBCL   7/13/2004   New   Spleen  
4   MF659   F   86   Foll g1   7/20/2004   Leuk, ritux   Node  
5   MF678   M   65   SLL   7/29/2004   New   Node  
6   MF685   F   88   Foll g2   8/5/2004   New   Node  
7   MF702   M   66   Foll g1   8/20/2004   R-CVP   Node  
8   MF779   M   50   Foll g2   10/29/2004   CHOP   Node  
9   MF824   M   61   DLBCL   12/1/2004   New   Extra  
10   MF825   M   51   Foll g1   12/1/2004   Ritux   Node  
11   MF849   M   70   DLBCL   12/28/2004   Fludara   Node  
12   MF886   F   42   Foll g3   2/1/2005   Leuk, ritux   Node  
13   MF965   M   67   Foll g3   4/7/2005   CHOP   Node  
14   MF974   M   48   DLBCL   4/12/2005   FND   Spleen  
15   MF978   M   68   DLBCL   4/14/2005   New   Node  
16   MF995   M   73   Foll g2   4/27/2005   New   Node  
17   MF1005   M   56   High gr   5/6/2005   R-CHOP   Spleen  
18   MF1024   M   73   MCL   5/16/2005   New   Spleen  
19   MF1050   F   75   Foll gr1   5/24/2005   New   Node  
20   MF1054   F   55   Foll gr1   5/26/2005   New   Node  
21   MF1059   M   66   MCL   6/1/2005   New   Extra  
22   MF1062   F   49   Foll gr1   6/3/2005   New   Node  
23   MF1065   M   52   Foll gr1   6/4/2005   CHOP   Extra  
24
 
MF1076
 
M
 
69
 
High gr
 
6/14/2005
 
New
 
Node
 

Patient no.

Hem ID

Sex

Age, y

Histology

Biopsy date

Treatment

Tissue
1   MF634   M   40   DLBCL   6/28/2004   New   Node  
2   MF644   M   69   DLBCL   7/9/2004   New   Spleen  
3   MF650   F   60   DLBCL   7/13/2004   New   Spleen  
4   MF659   F   86   Foll g1   7/20/2004   Leuk, ritux   Node  
5   MF678   M   65   SLL   7/29/2004   New   Node  
6   MF685   F   88   Foll g2   8/5/2004   New   Node  
7   MF702   M   66   Foll g1   8/20/2004   R-CVP   Node  
8   MF779   M   50   Foll g2   10/29/2004   CHOP   Node  
9   MF824   M   61   DLBCL   12/1/2004   New   Extra  
10   MF825   M   51   Foll g1   12/1/2004   Ritux   Node  
11   MF849   M   70   DLBCL   12/28/2004   Fludara   Node  
12   MF886   F   42   Foll g3   2/1/2005   Leuk, ritux   Node  
13   MF965   M   67   Foll g3   4/7/2005   CHOP   Node  
14   MF974   M   48   DLBCL   4/12/2005   FND   Spleen  
15   MF978   M   68   DLBCL   4/14/2005   New   Node  
16   MF995   M   73   Foll g2   4/27/2005   New   Node  
17   MF1005   M   56   High gr   5/6/2005   R-CHOP   Spleen  
18   MF1024   M   73   MCL   5/16/2005   New   Spleen  
19   MF1050   F   75   Foll gr1   5/24/2005   New   Node  
20   MF1054   F   55   Foll gr1   5/26/2005   New   Node  
21   MF1059   M   66   MCL   6/1/2005   New   Extra  
22   MF1062   F   49   Foll gr1   6/3/2005   New   Node  
23   MF1065   M   52   Foll gr1   6/4/2005   CHOP   Extra  
24
 
MF1076
 
M
 
69
 
High gr
 
6/14/2005
 
New
 
Node
 

DLBCL indicates diffuse large B-cell lymphoma; new, newly diagnosed and untreated; foll g1, follicular grade 1; leuk, Leukeran; ritux, rituximab; SLL, small lymphocytic lymphoma; foll g2, follicular grade 2; R-CVP, rituximab, cyclophosphamide, vincristine, and prednisone; CHOP, cyclophosphamide, doxorubicin, vincristine, and prednisone; extra, extranodal; fludara, fludarabine; foll g3, follicular grade 3; FND, fludarabine, mitoxantrone, and dexamethasone; high gr, high-grade B-cell lymphoma otherwise unspecified; R-CHOP, rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone; MCL, mantle cell lymphoma; and Hem ID, Hematology Research Laboratory identification number.

Close Modal

or Create an Account

Close Modal
Close Modal